Watchlist Price Alert

MBX Biosciences Inc. Comm... (MBX)

NASDAQ: MBX · Real-Time Price · USD

12.04

0.76 (6.74%)

At close: May 02, 2025, 3:59 PM

12.01

-0.29%

After-hours: May 02, 2025, 05:05 PM EDT

MBX Biosciences Common Stock Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023
Net Income	-15.59M	-18.14M	-15.86M	-12.34M	-8.84M	-10.16M	-7.61M
Depreciation & Amortization	58K	75K	63K	48K	41K	40K	39K
Stock-Based Compensation	1.49M	1.19M	n/a	n/a	1.02M	596K	n/a
Other Working Capital	-1.27M	542K	1.44M	-40K	-2.55M	1.53M	-529K
Other Non-Cash Items	-1.37M	-560K	505K	1.15M	-506K	9K	86K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-627K	2.77M	2.02M	434K	-2.86M	1.79M	102K
Operating Cash Flow	-16.04M	-14.66M	-13.27M	-10.71M	-11.15M	-7.73M	-7.38M
Capital Expenditures	-92K	-57K	-452K	-273K	-55K	-22K	-31K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-87.5M	-127.73M	-15.69M	-8.55M	-33.9M	-20.58M	n/a
Sales Maturities Of Investments	20.25M	27M	8.25M	24.25M	5M	2M	20M
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-67.34M	-100.79M	-7.89M	15.43M	-28.95M	-18.61M	19.97M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-132K	235.81M	n/a	n/a	19K	68.5M	n/a
Financial Cash Flow	-132K	235.81M	-1.76M	183K	19K	68.5M	634K
Net Cash Flow	-83.51M	120.36M	n/a	n/a	-40.08M	42.16M	n/a
Free Cash Flow	-16.13M	-14.72M	-13.72M	-10.98M	-11.2M	-7.75M	-7.41M